259 related articles for article (PubMed ID: 7903845)
1. Can the H2 receptor antagonists change the natural history of duodenal ulcer disease?
Bardhan KD
Am J Gastroenterol; 1994 Jan; 89(1):3-6. PubMed ID: 7903845
[No Abstract] [Full Text] [Related]
2. Response to "H2-receptor antagonists and duodenal ulcer recurrence".
Kurata JH; Nogawa AN; Koch GG
Am J Gastroenterol; 1988 Dec; 83(12):1427-9. PubMed ID: 2904219
[No Abstract] [Full Text] [Related]
3. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
Thomas JM; Misiewicz G
Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
[No Abstract] [Full Text] [Related]
4. [Histamine H2-receptor antagonists as new anti-ulcer agents].
Takemoto T
Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
[No Abstract] [Full Text] [Related]
5. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Hentschel E
Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
[No Abstract] [Full Text] [Related]
6. Bedtime treatment of duodenal ulcer.
Drug Ther Bull; 1985 Dec; 23(24):95-6. PubMed ID: 2866081
[No Abstract] [Full Text] [Related]
7. Ranitidine and cimetidine for duodenal ulcer.
Langman MJ; Henry DA; Ogilvie A
Scand J Gastroenterol Suppl; 1981 Jun; 69():115-7. PubMed ID: 6119774
[No Abstract] [Full Text] [Related]
8. [Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine].
Hüttemann W
Fortschr Med; 1983 Jan; 101(4):139-41. PubMed ID: 6131857
[TBL] [Abstract][Full Text] [Related]
9. [Which drug for peptic ulcer?].
Hameeteman W; Tytgat GN
Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
[No Abstract] [Full Text] [Related]
10. [Pathogenesis, diagnosis and therapy of ulcer disease. Therapy. 4: Pharmacological basis and therapy with H2 antagonist].
Med Welt; 1983 Dec; 34(49):20, 22. PubMed ID: 6140616
[No Abstract] [Full Text] [Related]
11. Maintenance therapy of duodenal ulcer with H2-receptor antagonists--a meta-analysis.
Palmer RH; Frank WO; Karlstadt R
Aliment Pharmacol Ther; 1990 Jun; 4(3):283-94. PubMed ID: 1983324
[TBL] [Abstract][Full Text] [Related]
12. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.
Freston JW
Am J Gastroenterol; 1987 Dec; 82(12):1242-9. PubMed ID: 2891294
[TBL] [Abstract][Full Text] [Related]
13. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
14. H2-receptor antagonists: development and application.
Feldman S
N Engl Reg Allergy Proc; 1986; 7(4):362-6. PubMed ID: 2886903
[TBL] [Abstract][Full Text] [Related]
15. Treatment of duodenal ulcer.
Eliakim R; Rachmilewitz D
Rev Clin Basic Pharm; 1985; 5(3-4):215-33. PubMed ID: 2881325
[TBL] [Abstract][Full Text] [Related]
16. H2-receptor antagonists an Helicobacter pylori eradication.
Lamers CB
Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
[TBL] [Abstract][Full Text] [Related]
17. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
Simon B; Müller P; Dammann HG
Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
[TBL] [Abstract][Full Text] [Related]
18. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
Del Soldato P; Ghiorzi A; Cereda E; Donetti A
Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
[TBL] [Abstract][Full Text] [Related]
19. [Ranitidine: an alternative to cimetidine in the treatment of duodenal ulcer].
Simon B; Müller P; Dammann HG; Kather H
MMW Munch Med Wochenschr; 1981 Jun; 123(25):1049-50. PubMed ID: 6114426
[No Abstract] [Full Text] [Related]
20. Duodenal ulcer. Who should have long-term maintenance therapy?
Zuckerman G
Postgrad Med; 1987 Oct; 82(5):52-3, 57-8, 60. PubMed ID: 2890147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
